Growth hormone-releasing hormone (GHRH) antagonist attenuates cell motility of human endometrial cancer by down-regulating Twist and N-Cadherin expression

被引：0
|
作者：
Wu, Hsien-Ming [1 ]
Schally, Andrew V. [2 ]
Leung, Peter C. K. [3 ]
机构：
[1] Chang Gang Mem Hosp, Tao Yuan, Taiwan
[2] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA
[3] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-4769
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4769
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression
    Wu, Hsien-Ming
    Huang, Hong-Yuan
    Schally, Andrew V.
    Chao, Angel
    Chou, Hung-Hsueh
    Leung, Peter C. K.
    Wang, Hsin-Shih
    ONCOTARGET, 2017, 8 (03) : 4410 - 4421
  • [2] Agonists of growth hormone-releasing hormone (GHRH) inhibit human experimental cancers in vivo by down-regulating receptors for GHRH
    Schally, Andrew V.
    Wang, Haibo
    He, Jinlin
    Cai, Renzhi
    Sha, Wei
    Popovics, Petra
    Perez, Roberto
    Vidaurre, Irving
    Zhang, Xianyang
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2018, 115 (47) : 12028 - 12033
  • [3] Inhibition of growth of experimental human endometrial cancer by an antagonist of growth hormone-releasing hormone
    Engel, JB
    Keller, G
    Schally, AV
    Toller, GL
    Groot, K
    Havt, A
    Armatis, P
    Zarandi, M
    Varga, JL
    Halmos, G
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (06): : 3614 - 3621
  • [4] Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone
    Zhao, Lin
    Yano, Tetsu
    Osuga, Yutaka
    Nakagawa, Shunsuke
    Oishi, Hajime
    Wada-Hiraike, Osamu
    Tang, Xiaohui
    Yano, Naomi
    Kugu, Koji
    Schally, Andrew V.
    Taketani, Yuji
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2008, 32 (03) : 593 - 601
  • [5] Expression of growth hormone-releasing hormone in human primary endometrial carcinomas
    Chatzistamou, I
    Schally, AV
    Pafiti, A
    Kiaris, H
    Koutselini, H
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (03) : 381 - 386
  • [6] Expression of growth hormone-releasing hormone (GHRH) and splice variants of GHRH receptors in human experimental prostate cancers
    Plonowski, A
    Schally, AV
    Busto, R
    Krupa, M
    Varga, JL
    Halmos, G
    PEPTIDES, 2002, 23 (06) : 1127 - 1133
  • [7] Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers
    Kahán, Z
    Arencibia, JM
    Csernus, VJ
    Groot, K
    Kineman, RD
    Robinson, WR
    Schally, AV
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02): : 582 - 589
  • [8] Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines
    Barabutis, N.
    Schally, A. V.
    BRITISH JOURNAL OF CANCER, 2008, 98 (11) : 1790 - 1796
  • [9] Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines
    N Barabutis
    A V Schally
    British Journal of Cancer, 2008, 98 : 1790 - 1796
  • [10] Growth hormone-releasing hormone (GHRH) activates E-cadherin/β-catenin signalling pathway in human prostate cells
    Carmena, M. J.
    Munoz Moreno, L.
    Prieto, J.
    Bajo, A. M.
    FEBS JOURNAL, 2014, 281 : 468 - 469
12345